Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.

Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.

Item
http://www.wikidata.org/entity/Q44343349
The Clinical Applications of Extended-Release Abuse-Deterrent Opioids.A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic painEffects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteersPsychiatric Comorbidity Is Associated Prospectively with Diminished Opioid Analgesia and Increased Opioid Misuse in Patients with Chronic Low Back PainDrug Formulation Advances in Extended-Release Medications for Pain Control.An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release Hydrocodone.Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain.A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain.Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain.Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study.All failures count.Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain.Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials.Preclinical and Clinical Pharmacology of Hydrocodone for Chronic Pain: A Mini Review
P2860

Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.

Item
http://www.wikidata.org/entity/Q44343349
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Single-entity hydrocodone exte ...... ind, placebo-controlled study.
@en
Single-entity hydrocodone exte ...... ind, placebo-controlled study.
@nl
type
label
Single-entity hydrocodone exte ...... ind, placebo-controlled study.
@en
Single-entity hydrocodone exte ...... ind, placebo-controlled study.
@nl
prefLabel
Single-entity hydrocodone exte ...... ind, placebo-controlled study.
@en
Single-entity hydrocodone exte ...... ind, placebo-controlled study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Single-entity hydrocodone exte ...... ind, placebo-controlled study.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921